Item 8.01 Other Events.

On October 4, 2021, NeuroOne Medical Technologies Corporation (the "Company") adopted the NeuroOne Medical Technologies Corporation 2021 Inducement Plan (the "Plan"), pursuant to which the Company reserved 420,350 shares of its common stock to be used exclusively for grants of awards to individuals who were not previously employees or directors of the Company, as an inducement material to the individual's entry into employment with the Company within the meaning of Rule 5635(c)(4) of the Nasdaq Listing Rules. The Plan was approved by the Company's Board of Directors without stockholder approval pursuant to Rule 5635(c)(4).

The foregoing summary of the terms of the Plan is not intended to be complete and is qualified in its entirety by reference to the Plan and the form of award agreements adopted under the Plan, copies of which are included hereto as Exhibits 10.1 and 10.2, respectively, and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.





 (d) Exhibits




Exhibit No.   Description
10.1            NeuroOne Medical Technologies Corporation 2021 Inducement Plan
10.2            Form of Stock Option Grant Notice, Option Agreement and Notice of
              Exercise under the NeuroOne Medical Technologies Corporation 2021
              Inducement Plan
104           Cover Page Interactive Data File (embedded within Inline XBRL document).




                                       1

© Edgar Online, source Glimpses